ALGN
Align Technology Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · Nasdaq Composite 0.03% · S&P 500 0.02% · Russell 1000 0.02% · Russell 3000 0.02% · US Stock Market 0.02%$147.61-1.40%
as of market close, Sep 18, 2026
☾ AH — —
ALGN — Align Technology Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Volume
100.0200.0300.0400.0500.0600.0700.0020.0M$147.61—20162019202120242026
2026-09-18
Price$147.61
MA20$170.50
MA50$162.08
Vol4.3M
Key stats
Price data
- Price
- $147.61
- Change YTD
- -5.47%
- Next earnings
- Nov 4, 2026
- Market cap
- 10.5B
- Enterprise value
- 9.5B
- Shares outstanding
- 71M
- 52W low
- $122.00
- 52W high
- $200.44
- From 52W high
- -26.36%
- From 52W low
- +20.99%
- 52W range
- 33%
- Beta
- 1.64
Volume
- Rel volume
- 1.78×
- 30D volume
- 843.3K
- 30D $ vol
- 134.9M
Fundamentals
- Sales (ttm)
- 4.1B
- Sales/share
- $58.27
- EPS (ttm)
- $5.76
- FCF (ttm)
- 633.6M
- FCF/share
- $8.92
- Book value/share
- $59.58
- Net margin
- 9.99%
- ROE
- 9.77%
- ROA
- 6.44%
- Current ratio
- 1.40
Growth (CAGR, ttm) · 10Y
- Sales
- +4.41%+3.47%+3.57%+15.91%
- Net income
- -5.49%+9.60%-9.95%+9.48%
- FCF
- +0.32%+1.18%-6.68%+13.41%
- Shares
- -2.00%-2.45%-2.10%-1.19%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -2.79%+12.39%-8.09%+10.84%
- Sales/share
- +6.54%+6.07%+5.79%+17.30%
- FCF/share
- +2.37%+3.72%-4.67%+14.78%
- Book value/share
- +10.38%+7.81%+6.82%+18.02%
- Price
- +11.35%-23.15%-27.14%+4.63%
- Total return
- +11.35%-23.15%-27.14%+4.63%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 25.6×
- P/OI (ttm)
- 19.1×
- Fwd P/E
- 11.8×
- P/S (ttm)
- 2.5×
- P/B (mrq)
- 2.5×
- P/FCF (ttm)
- 16.6×
- EV/EBITDA (fy)
- 11.8×
- EV/Sales (ttm)
- 2.3×
- FCF yield (ttm)
- 6.04%
- Buyback yield (realized, 1y)
- 2.00%
- Shareholder yield (realized, 1y)
- 2.00%
- Buyback yield (cash, ttm)
- 2.36%
- Shareholder yield (cash, ttm)
- 2.36%
Vs own 10Y history
- P/E
- 12th
- P/OI
- 4th
- P/S
- 2nd
- P/B
- 2nd
- P/FCF
- 2nd
Bar = where today’s multiple sits in ALGN’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-09-18
1D
-1.40%
5D
-2.13%
1M
-12.09%
3M
-18.93%
YTD
-5.47%
1Y
+11.34%
5Y
-79.48%
Financial statements
Open full ALGN financials →Loading financial statements…
Related Healthcare
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | -5.94% | +0.04% |
| JNJ | Johnson & Johnson | -0.41% | -0.09% |
| ABBV | AbbVie Inc. | +1.95% | -0.02% |
| MRK | Merck & Co. Inc. | +8.66% | -0.19% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -4.32% | +0.45% |
| TMO | Thermo Fisher Scientific Inc. | +10.60% | -1.04% |
| AMGN | Amgen Inc. | -9.32% | +1.55% |
| GILD | Gilead Sciences Inc. | +4.65% | -0.52% |
Align Technology Inc. (ALGN) trades at $147.61 with a live price and an interactive chart covering 25+ years of daily price history, plus key valuation metrics. ChartRow also publishes ALGN’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full ALGN financial statements →
